Evogliptin
Product Specifications
CAS Number
1222102-29-5
Target
Proteasome, Autophagy, Others
Related Pathways
Proteases/Proteasome, Ubiquitination, Others, Autophagy
Bioactivity
Evogliptin (DA-1229) is a DPP4 inhibitor with oral activity. Evogliptin has significant and lasting hypoglycemic effect in mouse model. Evogliptin inhibits the production of the fibrosis and inflammatory in hepatocytes signals by inducing autophagy. Evogliptin can be used to study type 2 diabetes, chronic liver inflammation, osteoporosis and renal impairment.
Smiles
C(C[C@@H](CC1=C(F)C=C(F)C(F)=C1)N)(=O)N2[C@H](COC(C)(C)C)C(=O)NCC2
Molecular Formula
C19H26F3N3O3
Molecular Weight
401.42
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-61337R-PE-Cy7-TR 20 µL
NOTCH4 Recombinant Antibody, PE-Cy7 Conjugated
Sign In for Pricing
View Details 
NBP1-99050-0.5mg 0.5 mg
Recombinant Human N-Acetyl-D-Glucosamine Kinase/NAGK Protein
Sign In for Pricing
View Details